Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

It may not sound surprising that treating obesity in adolescents and teens may have positive mental health impacts, but ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...

New Yorkers are brazenly reselling prescription diabetic and weight ... “In addition, injectable weight loss drugs are often not covered by insurance, making some patients more likely to pay ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...

The number of U.S. children who suffer seizures after swallowing prescription medications or illicit drugs has doubled in ...

One of the biggest changes takes effect in 2025. Part D drug plans must cap out-of-pocket spending on covered drugs at $2,000 ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...